In NEOVA formulations, AHK-Cu is used exclusively in the Tricomin clinical hair care system
After decades with no disease-modifying drug, 20242026 finally delivered the first targeted therapies: Novartis ianalumab met both NEPTUNUS-1 & NEPTUNUS-2 Phase 3 endpoints and won FDA Breakthrough Therapy status in Jan 2026, and J&Js nipocalimab was positive in the Phase 2 DAHLIAS trial ( The Lancet )
Check your state Medicaid agencys drug billing manual or fee schedule for current J3420 coverage policy and the applicable rate
last year, Mark Mikhail, CEO of one of two main compounding pharmacies, was appointed to the pro-Kennedy Maha Pac, where he has advocated to lift the regulations that have kept pharmacies from producing unproven peptides
With rising demand for skincare, anti-ageing, and fairness treatments, glutathione tablets have become popular in the cosmetic and dermatology industries